Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Option Care Health, Inc.BIOS · Entity 4126 | Director | June 03, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Option Care Health, Inc.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Cash-Settled Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 18,905 |
Reported balance
After 2019-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-03 · Grant · Acquired 18,905 · Balance 18,905 F1: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. F2: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.
F2: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 5, 2019 21:03 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCash-Settled Restricted Stock Unit · Derivative | 18,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020904 · form4.xml · derivative · entry 1 Bronfein Michael G · CIK 0001345949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,905 Underlying: Common Stock, $.0001 Par Value · 18,905 shares Expires not disclosed F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:54 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 43,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016491 · form4.xml · nonDerivative · entry 1 Bronfein Michael G · CIK 0001345949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,395 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2019 Annual Meeting. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 19:59 UTC | Option Care Health, Inc. BIOS · Entity 4126 | SaleCommon Stock, $.0001 Par Value | 27,000 | $2.69 | $72,732.60 |
DisclosureSEC source: 0001127602-17-027723 · form4.xml · nonDerivative · entry 1 Bronfein Michael G · CIK 0001345949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,669 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions in prices ranging from $2.68 to $2.71, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 02, 2017 Filed May 4, 2017 16:58 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 49,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016829 · form4.xml · nonDerivative · entry 1 Bronfein Michael G · CIK 0001345949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,669 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.